menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Cost-Benefit Calculus of CT Angiograms

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Measuring precise risks in medicine can be a tricky proposition. Factoring risk into cost-benefit analyses can make the situation even less clear. In many ways, this is where we stand with coronary computed tomography angiograms: a scan can be immediately helpful in emergent circumstances, but at other points in the clinical care spectrum, the value of that scan is more difficult to estimate. Dr. Mark Hlatky, professor of medicine and professor of health research and policy at Stanford University School of Medicine, juxtaposes the medical aspects of these tests with the money we spend on them. Dr. Janet Wright hosts.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Measuring precise risks in medicine can be a tricky proposition. Factoring risk into cost-benefit analyses can make the situation even less clear. In many ways, this is where we stand with coronary computed tomography angiograms: a scan can be immediately helpful in emergent circumstances, but at other points in the clinical care spectrum, the value of that scan is more difficult to estimate. Dr. Mark Hlatky, professor of medicine and professor of health research and policy at Stanford University School of Medicine, juxtaposes the medical aspects of these tests with the money we spend on them. Dr. Janet Wright hosts.

Facebook Comments

Schedule28 Mar 2024